|Bid||258.98 x 800|
|Ask||259.51 x 1300|
|Day's Range||250.00 - 259.85|
|52 Week Range||132.95 - 259.85|
|Beta (5Y Monthly)||0.89|
|PE Ratio (TTM)||51.88|
|Earnings Date||Oct 28, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||267.79|
Amedisys (AMED) possesses solid growth attributes, which could help it handily outperform the market.
An impressive Q3 performance by Amedisys' (AMED) Home health and hospice amid the pandemic-led business disruptions buoys optimism.
AMED earnings call for the period ending September 30, 2020.